Retail Healthcare Sector

Hellenic Dynamics

Market Cap: UK£1.4m

Engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe.

Galera Therapeutics

Market Cap: US$1.8m

A biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.

OMID Holdings

Market Cap: US$1.8m

A health and wellness company, engages in the manufacture and sale of CBD-based products.

Aion Therapeutic

Market Cap: CA$2.5m

Engages in the health and wellness business in the United States.

VGI Health Technology

Market Cap: AU$2.8m

VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies.

Blueberries Medical

Market Cap: CA$2.5m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

Algernon Pharmaceuticals

Market Cap: CA$2.5m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

1933 Industries

Market Cap: CA$2.5m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

Lifeline Biotechnologies

Market Cap: US$1.7m

Operates as a medical technology company in the United States.

Medicine Man Technologies

Market Cap: US$1.7m

Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.

RespireRx Pharmaceuticals

Market Cap: US$1.7m

Engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders.

Physiomics

Market Cap: UK£1.3m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

Ayala Pharmaceuticals

Market Cap: US$1.7m

A clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.

Imagion Biosystems

Market Cap: AU$2.6m

Provides medical imaging technologies using magnetic resonance.

Binovi Technologies

Market Cap: CA$2.3m

Engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally.

City View Green Holdings

Market Cap: CA$2.3m

A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.

Protagenic Therapeutics

Market Cap: US$1.6m

A biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders.

United American Healthcare

Market Cap: US$1.6m

Through its subsidiaries, provides contract manufacturing services to the medical device industry.

Rize Oncology

Market Cap: CA$2.3m

Engages in the development of oncology therapeutics.

Syra Health

Market Cap: US$1.6m

A healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States.

Helix BioMedix

Market Cap: US$1.6m

Operates as a specialty dermatology and consumer products skin health company in the United States.

SOHM

Market Cap: US$1.6m

Develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States.

Bio-Path Holdings

Market Cap: US$1.5m

Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.

Hempshire Group

Market Cap: CA$2.1m

Engages in the production and distribution of CBD Hemp smokes.

American Green

Market Cap: US$1.5m

Operates as a technology company in the medical cannabis industry in the United States.

MyndTec

Market Cap: CA$2.1m

A medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada and the United States.

GelStat

Market Cap: US$1.5m

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products.

CBD of Denver

Market Cap: US$1.5m

Engages in developing and commercializing cannabidiol (CBD) products.

West Island Brands

Market Cap: CA$2.0m

Engages in the medical marijuana business.

Procyon

Market Cap: US$1.5m

Manufactures and markets wound and skin care products primarily in the United States.

Alterola Biotech

Market Cap: US$1.5m

A pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.

Salarius Pharmaceuticals

Market Cap: US$1.4m

Operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need.

Kaya Holdings

Market Cap: US$1.4m

A vertically integrated legal cannabis enterprise, engages in the operation of psychedelic treatment clinics and medical cannabis dispensaries primarily in the United States.

Ocean Biomedical

Market Cap: US$1.4m

A biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States.

Restart Life Sciences

Market Cap: CA$2.0m

Through its subsidiaries, operates as a biotechnology company worldwide.

Osteopore

Market Cap: AU$2.2m

A regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, the United States, Malaysia, Indonesia, Netherlands, Thailand, Australia, and internationally.